Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Diabetes
•
Gastroenterology
•
Neurology
•
Autonomic Neurology
•
Endocrinology
•
Neuro-Gastroenterology
•
Gastrointestinal Functional & Motility Disorders
Do 5HT4 agonists such as Metoclopramide actually lead to improvement in symptoms for patients with diabetes related gastroparesis?
Related Questions
Do you recommend Alpha Lipoic Acid to patients with diabetic polyneuropathy?
Do you recommend neuromodulation treatments with an implantable device for patients with chronic painful diabetic neuropathy who have not responded to common oral therapies such as Gabapentin and Amitriptyline?
How do you counsel patients on the use of compounded weight loss medications?
Do patients with advanced chronic kidney disease tend to have falsely high HbA1c or falsely low HbA1c levels?
When should metformin be stopped before surgery and when is it considered safe to resume?
Is there a role for intermittent fasting as part of the management of a patient with long-standing type 2 diabetes and consistently poor glycemic control despite maximal therapy?
Do you use the homeostatic model assessment (HOMA) to assess for insulin resistance and change your clinical management of patients?
When do you recommend screening patients with T2DM for heart failure?
Will Omnipod 5 work well in patients receiving bursts of corticosteroids or in those on hemodialysis?
Which screening method for diabetes do you consider to be the most sensitive?
